Thursday, January 23, 2014

Biogen Idec CEO George A. Scangos Joins Headline Speakers at CED Life Science Conference 2014

          Joins FDA Commissioner Margaret Hamburg, among other notable speakers

DURHAM, NC, January 23, 2014 -- George A. Scangos, PhD, CEO of Biogen Idec has been announced as a headline speaker for the CED Life Science Conference 2014. He is scheduled to deliver a Leadership Perspective on the state of the industry at the conference, which takes place February 26 – 27, 2014 at the Raleigh Convention Center in Raleigh, NC.

Scangos joins other prominent speakers, including Margaret Hamburg, Commissioner of the FDA, Christopher Austin, Director of NIH’s National Center for Advancing Translational Sciences, and Clayton Christensen, Harvard Business School Professor and author of The Innovator’s Dilemma. A complete agenda is available at

Conference Co-Chair Anne Whitaker, President of North America Pharmaceuticals, Sanofi, said, “With the dynamic ever-changing healthcare environment in which we are operating, to make a true difference in healthcare in 2020  we must collaborate to find new innovative ways of meeting the needs of the patient.  The discussion at the CED Life Science Conference is sure to be insightful given our speakers from the likes of George Scangos to Margaret Hamburg. To succeed today we must all have the entrepreneurial spirit that the CED Life Science Conference fosters and promotes.”

The CED Life Science Conference 2014, produced in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences Organization (NCBIO), is the southeast’s largest industry gathering.  This year’s theme is Healthcare in 2020, a look ahead to the anticipated convergence of policy, technology, and practice.  Panelists include executives from Sanofi, Envivo Pharmaceuticals, Google Ventures, Morgan Stanley, Healthcare Royalty Partners , PatientsLikeMe, Quintiles, United Therapeutics, Kids v Cancer, Teva Pharmaceuticals, SAS Center for Health Analytics, Partners HealthCare, Oliver Wyman’s Health and Life Sciences Practice, Blue Cross and Blue Shield of North Carolina, and the Deloitte Center for Health Solutions.

The conference offers high-level networking and business partnering opportunities, a workshop for entrepreneurs, and the annual State of the Life Sciences Industry Report.
Registration is open, with best-available rates in effect through February 20, 2014.

About CED
CED’s mission is to identify, enable and promote high-growth, high-impact companies and to accelerate the entrepreneurial culture within the Research Triangle area and throughout North Carolina.

About the North Carolina Biotechnology Center

NC Biotech
is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.


is the trade association for North Carolina’s biosciences industry. The Organization has more than 160 members working in human and animal therapeutics, diagnostics, medical devices, and agricultural and industrial biotechnology. 

Press Contact:
Ann Revell-Pechar
CED Communications Consultant

No comments:

Post a Comment